Travere Therapeutics/ US89422G1076 /

1/27/2023 9:59:54 PM	Chg. +0.02	Volume	Bid-	Ask-	High	Low
21.87USD	+0.09%	20,322 Turnover: 445,148.64	-Bid Size: -	-Ask Size: -	22.10	21.63

GlobeNewswire 3/23/2022 Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busin...

GlobeNewswire 3/21/2022 Travere Therapeutics Submits New Drug Application for Sparsentan for the Treatment of IgA Nephropath...

GlobeNewswire 3/14/2022 Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 3/9/2022 Travere Prices Upsized $275 Million Convertible Senior Notes Offering

GlobeNewswire 3/8/2022 Travere Announces Proposed Convertible Senior Notes Offering

GlobeNewswire 3/3/2022 Travere Therapeutics to Present at the Barclays Global Healthcare Conference

GlobeNewswire 2/28/2022 UPDATE: American Kidney Fund Celebrates Individuals’ ‘Kidney Moments’ During Kidney Month

GlobeNewswire 2/28/2022 Travere Therapeutics Recognizes Rare Disease Day 2022 and Raises Awareness for People Living with Ra...

GlobeNewswire 2/24/2022 Travere Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire 2/14/2022 Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 2/10/2022 Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire 2/9/2022 Travere Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire 1/12/2022 Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 1/10/2022 Travere Therapeutics Provides Corporate Update and 2022 Outlook

GlobeNewswire 1/4/2022 Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer

GlobeNewswire 12/15/2021 Travere Therapeutics Announces Positive Topline Results from the Ongoing Phase 1/2 COMPOSE Study of ...

GlobeNewswire 12/14/2021 Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 11/18/2021 NBA Hall-of-Famer Alonzo Mourning Shares Personal Story to Raise Kidney Disease Awareness

GlobeNewswire 11/11/2021 Travere Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire 11/2/2021 Travere Therapeutics to Present Abstracts at American Society of Nephrology Kidney Week 2021

GlobeNewswire 10/28/2021 Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress

GlobeNewswire 10/14/2021 Travere Therapeutics to Report Third Quarter 2021 Financial Results

GlobeNewswire 10/13/2021 Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 10/12/2021 Travere Therapeutics Announces Transition of Chief Medical Officer

GlobeNewswire 9/15/2021 Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Spar...